Feasibility of Check-Cap's P1 Capsule System Screening

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

143 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-20

Study Completion Date

2019-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, Single arm, Multi-Center

1. To establish the safety and preliminary efficacy of the Check-Cap System in patients with negative FOBT (Fecal Occult Blood Test)
2. To collect data about the overall imaging of the colon internal surface during the passage of the capsule
3. To develop a correlation map between the imaging of the polyps by optical colonoscopy vs. the images of same polyps by the Check-Cap capsule vs. the imaging of same polyps by CT Colonography \[CTC\] (in patients which were referred after positive CTC examination)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation C-Scan System in Providing Structural Information and Polypoid Lesions in the Colon of Healthy Subjects

NCT04038736

Risk for Colorectal Cancer

COMPLETED NA

Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers

NCT02503631

Colorectal Neoplasms Digestive System Diseases Colonic Diseases +1 more

TERMINATED

Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon

NCT05268406

Healthy Subjects

UNKNOWN NA

Polyp Measurement Device

NCT03856255

Colorectal Cancer

TERMINATED NA

Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening

NCT02738359

Colon Cancer Rectum Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Title:

Outside USA \[OUS\] Pilot Multi-center prospective feasibility study

Objectives:

Primary:

To establish the safety and preliminary efficacy of the Check-Cap System in patients with negative FOBT (Fecal Occult Blood Test) or FIT

Secondary:

* To evaluate the safety of the device in terms of total and segmental transit time and to study the effect of the presence of polyps and variable colon dimensions on these parameters.
* To monitor the functionality of the activation mechanism and of the scanning circuitry (transmitter detectors).
* To collect data about the overall imaging of the colon internal surface during the passage of the capsule
* To develop a correlation map between the imaging of the polyps by optical colonoscopy vs. the images of same polyps by the Check-Cap capsule vs. the imaging of same polyps by CT Colonography (in patients which were referred after positive CTC examination)
* To estimate the total radiation exposure to each patient.
* To measure the distribution of the contrast material within the colon.

Design:

Prospective, Single arm, Multi-Center

Patient population:

Group A - First in Man:

Male and female subjects older than 40 and younger than 75 years old that are eligible for CRC screening and meet the eligibility criteria for study enrollment.

The study population will be enriched with up to 45 patients with known polyps detected by CTC or colonoscopy, in addition to 15 patient of the device's normal cohort.

All patients that are eligible for enrollment in the study will be tested by FOBT (Fecal Occult Blood Test) After the Capsule test, they will be referred for optical colonoscopy as part of the study

Group B - CE Pilot:

Male and female subjects older than 45 and younger than 75 years old that are eligible for CRC screening and meet the eligibility criteria for study enrollment.

All patients that are eligible for enrollment in the study will be tested by FIT ,. After the Capsule test they will be referred for optical colonoscopy Consenting patients with negative FIT testing scheduled for clinically-indicated optical colonoscopy without contraindication to either Check-Cap System imaging or optical colonoscopy, and able to undergo the bowel preparation necessary for optical colonoscopy.

Sample Size:

Total of 100 patients in both groups: A:3-5 + B: 55-57 subjects.

Study Procedure:

1. st visit - recruitment and screening meeting with the Principal Investigator \[PI\]. Subject will receive the FIT test kit with detailed instructions for executing the test.
2. nd visit - The FIT kits will be analyzed in order to diagnose the presence of blood in the stool.

If the bowel log form is complete and the bowel frequency is not less than once per 2 days the subject will be asked to sign the Informed Consent Form \[ICF\] for ingesting the capsule.
3. rd visit - Subject will ingest the capsule and continue ingestion of contrast material.
4. th visit - Subjects will return to the PI with the excreted capsule which is expected within 24-100 hours after ingestion.
5. th visit - All patients will undergo standard bowel preparation and optical colonoscopy between 10 and 30 days following imaging with the Check-Cap System.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ColoRectal Cancer Colonic Polyps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

P1 capsule and screening Cscopy

Male and female patients older than 40 and younger than 75 years old who volunteer for the experiment and qualify with the inclusion / Exclusion criteria.

The P1 Check-Cap capsule will be ingested by all participants. After the Capsule test, they will be referred for optical colonoscopy as part of the study

Group Type OTHER

The P1 Check-Cap capsule

Intervention Type DEVICE

The P1 Check-Cap capsule will be ingested by all participants. After the Capsule test, they will be referred for optical colonoscopy as part of the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The P1 Check-Cap capsule

The P1 Check-Cap capsule will be ingested by all participants. After the Capsule test, they will be referred for optical colonoscopy as part of the study

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female between 40 and 75 years of age.
* Subject is generally in good health.
* Subject is ready to undergo FOBT or FIT and Colonoscopy.
* Subject agrees to sign the informed consent.

Exclusion Criteria

* Subject has any known Gastro Intestinal \[GI\] related symptoms, complaints or GI diseases.
* Subject is contraindicated from performing colon cleansing (bowel prep.)
* Subject has cancer or other life threatening diseases or conditions.
* Female subject is pregnant.
* Subject underwent any abdominal surgery.
* Morbid Obese (BMI \> 40) subject.
* Subject has known drug abuse or alcoholism problem.
* Subject is under custodial care.
* Subject is currently or will be participating in other clinical study within 30 days prior to Check-Cap procedure

Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes